Skip to main content
BLCO
NYSE Industrial Applications And Services

Bausch + Lomb Reports Strong Q1 2026 Results with Significant Profitability and Cash Flow Improvement

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$15.5
Mkt Cap
$5.435B
52W Low
$10.45
52W High
$18.915
Market data snapshot near publication time

summarizeSummary

Bausch + Lomb reported robust first-quarter 2026 financial results, showcasing significant improvements in revenue, operating income, and cash flow from operations, alongside favorable legal outcomes and debt management.


check_boxKey Events

  • Strong Revenue Growth

    Total revenues increased by 9% to $1,244 million in Q1 2026, compared to $1,137 million in Q1 2025. On a constant currency basis, revenue growth was 6%, driven by all three segments: Vision Care (+8%), Pharmaceuticals (+14%), and Surgical (+7%).

  • Significant Profitability Improvement

    The company swung from an operating loss of $83 million in Q1 2025 to an operating income of $33 million in Q1 2026, a $116 million improvement. Net loss attributable to Bausch + Lomb Corporation also significantly narrowed from $212 million to $71 million.

  • Positive Cash Flow from Operations

    Cash flow from operating activities turned positive, providing $32 million in Q1 2026, a notable improvement from using $25 million in Q1 2025.

  • Debt Refinancing and Liquidity Enhancement

    Bausch + Lomb completed a $2,802 million term loan refinancing in January 2026, reducing its weighted average interest rate from 7.70% to 7.43%. The company also entered a new financing arrangement to sell receivables, generating $5 million in Q1 2026 and an additional $21 million in April 2026, enhancing liquidity.


auto_awesomeAnalysis

Bausch + Lomb's Q1 2026 results demonstrate a substantial operational turnaround, moving from an operating loss to a significant operating income and generating positive cash flow from operations. This improvement is driven by solid revenue growth across all segments and effective cost management. The successful refinancing of debt and positive resolutions in several key legal proceedings further strengthen the company's financial position and reduce future uncertainties. Investors should view these results as a strong indicator of improving fundamentals and financial health.

At the time of this filing, BLCO was trading at $15.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $10.45 to $18.92. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BLCO - Latest Insights

BLCO
Apr 29, 2026, 4:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
BLCO
Apr 29, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
8
BLCO
Apr 10, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
BLCO
Feb 18, 2026, 5:19 PM EST
Filing Type: 10-K
Importance Score:
7
BLCO
Feb 18, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
7
BLCO
Jan 02, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
8